Found: 6
Select item for more details and to access through your institution.
Mutations in G protein β subunits promote transformation and kinase inhibitor resistance.
- Published in:
- Nature Medicine, 2015, v. 21, n. 1, p. 71, doi. 10.1038/nm.3751
- By:
- Publication type:
- Article
Next-Generation cDNA Screening for Oncogene and Resistance Phenotypes.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0049201
- By:
- Publication type:
- Article
Identification of a novel oncogenic mutation of FGFR4 in gastric cancer.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-51217-6
- By:
- Publication type:
- Article
Azumamides A-E: Histone Deacetylase Inhibitory Cyclic Tetrapeptides from the Marine Sponge Mycale izuensis.
- Published in:
- Angewandte Chemie International Edition, 2006, v. 45, n. 45, p. 7553, doi. 10.1002/anie.200602047
- By:
- Publication type:
- Article
Cover Picture: Azumamides A-E: Histone Deacetylase Inhibitory Cyclic Tetrapeptides from the Marine Sponge Mycale izuensis / Total Synthesis of Azumamides A and E Z602047 Z602033 (Angew. Chem. Int. Ed. 45/2006).
- Published in:
- 2006
- By:
- Publication type:
- Other
ASP5878, a selective FGFR inhibitor, to treat FGFR3-dependent urothelial cancer with or without chemoresistance.
- Published in:
- Cancer Science, 2017, v. 108, n. 2, p. 236, doi. 10.1111/cas.13124
- By:
- Publication type:
- Article